AML Hub

AML Hub

Por: Scientific Education Support
The AML Hub is an open-access online resource dedicated to providing balanced, credible, and up-to-date medical education on acute myeloid leukemia (AML). Our aim is to enhance knowledge in AML through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management. Hosted on Acast. See acast.com/privacy for more information.
32 episodios disponibles

Latest episodes of the podcast AML Hub

Symposium | FLT3 mutations in AML: Types, prevalence, and clinical significance 14/01/2026
ASH 2025 | Pivekimab sunirine + Ven + Aza in unfit patients with ND CD123+ AML: Phase Ib/II efficacy and safety 13/01/2026
ASH 2025 | PARADIGM: Azacitidine + venetoclax vs conventional induction in fit adults with ND AML 18/12/2025
Clinical research round-up: Current and emerging treatments for IDH1-mutated AML 06/11/2025
Menin inhibitors in AML: Bridging the gap between trial data and clinical practice 24/10/2025
Addressing uncertainty in patient selection for transplant in AML 22/09/2025
Integrating menin inhibitors into the treatment landscape of AML: Future directions 03/09/2025
Know AML webinar | Closing remarks and Q&A 26/06/2025
Know AML webinar | How can physicians and patients communicate more clearly about mutation testing in AML going forward? 19/06/2025
Know AML webinar | Empowering patients to ask their physician the right questions during their AML journey 13/06/2025
Know AML webinar | What are mutations, and why do they matter in AML? 09/06/2025
“How I treat” a patient with DNMT3A-mutated AML in remission post intensive chemotherapy 03/10/2024
CPX-351 as first-line treatment in AML: Real-world data 30/09/2024
What is the impact of the 5th WHO classification and ICC of AML on diagnosis and treatment of high-risk AML​? 17/09/2024
What were your highlights from ASH 2023? 29/04/2024
What are the challenges associated with CAR T-cell therapy in patients with AML? 25/04/2024
How might the MORPHO trial of gilteritinib impact clinical practice? 08/04/2024
Risk stratification and guidelines in AML management 08/01/2024
How are new fludarabine conditioning combinations impacting transplant outcomes? 22/04/2022
Should pre-transplant MRD be used to guide treatment in AML? 10/07/2021
1 2 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA